CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

January 31, 2025

Conditions
Memory ImpairmentDementia, Vascular
Interventions
OTHER

CognivAID (Sailuotong)

CognivAiD is 27.27 mg of panax ginseng standard extract, 27.27 mg of gingo biloba standard extract and 5.46 mg of crocus sativus standard extract which is equal to 60mg /capsule .CognivAiD is available at 60 mg /cap 2 caps twice a day.

Trial Locations (1)

188770

RECRUITING

Raffles Hospital, Singapore

All Listed Sponsors
lead

Moleac Pte Ltd.

INDUSTRY